PHYSIOMICS PLC Logo

PHYSIOMICS PLC

PYC | IL

Overview

Corporate Details

ISIN(s):
GB00BDR6W943
LEI:
213800A71DSZ6ABMTQ91
Country:
United Kingdom
Address:
BEE HOUSE, OX14 4SB ABINGDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Physiomics PLC is a data-driven consultancy that accelerates and de-risks drug development for pharmaceutical and biotech companies. The company provides Model-Informed Drug Development (MIDD) services by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. Specializing in quantitative pharmacology (PK/PD, QSP) and computational biology, Physiomics enables clients to make smarter decisions from pre-clinical discovery through to clinical trials. With a strong focus on oncology, the company utilizes mathematical models and its Virtual Tumour™ technology to predict the effects of novel treatments, providing a more quantitative and translational understanding of new molecules.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for PHYSIOMICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-06 08:00
Regulatory News Service
Follow-on Contract with UK Biotech Client
English 9.5 KB
2025-07-16 08:00
Regulatory News Service
Contract Award
English 9.5 KB
2025-07-14 08:00
Earnings Release
Trading Update
English 12.0 KB
2025-07-10 08:00
Regulatory News Service
Platform Implementation and Partnership Expansion
English 17.6 KB
2025-05-29 08:00
Regulatory News Service
Physiomics Awarded Contract Extension
English 9.6 KB
2025-03-17 08:00
Regulatory News Service
Contract Award with new client
English 8.8 KB
2025-03-13 08:00
Report Publication Announcement
IMC Presentation on Company Website
English 8.3 KB
2025-03-06 08:00
Earnings Release
Interim Results
English 165.4 KB
2025-02-28 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 10.0 KB
2025-02-20 13:00
Major Shareholding Notification
Holding(s) in Company
English 52.0 KB
2025-02-17 14:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 14.5 KB
2025-02-13 08:01
Share Issue/Capital Change
WRAP Retail Offer for up to £70,000
English 28.6 KB
2025-02-13 08:00
Share Issue/Capital Change
Completion of Placing & WRAP Retail Offer Launch
English 18.5 KB
2025-01-30 08:00
Regulatory News Service
Publication of Peer Reviewed Article
English 12.7 KB
2025-01-28 12:30
Major Shareholding Notification
Holding(s) in Company
English 52.6 KB

Automate Your Workflow. Get a real-time feed of all PHYSIOMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PHYSIOMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN